Catalyst Wire Dossier Catalyst Wire Dossier

efpeglenatide

efpeglenatide · Hanmi Pharmaceutical Company Limited
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for efpeglenatide, covering 2021-10-15 to 2022-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise [Phase 3]

See pricing